Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...
Summit Therapeutics and Akeso published results for the Phase III HARMONi-2 trial, which tested ivonescimab, a bispecific ...
The lead asset is being developed for treating Group 2 pulmonary hypertension-heart failure with preserved ejection fraction. Credit: sasirin pamai / Shutterstock. Tectonic Therapeutic has reported ...
The trial enrolled 102 patients with metabolic-dysfunction-associated steatohepatitis. Credit: Emily frost / Shutterstock. Aligos Therapeutics has announced positive topline results from the Phase IIa ...
In Part A of the CIRRUS-HCM trial, patients with obstructive HCM received a single dose of 50, 100, or 200mg of EDG-7500. Credit: Inside Creative House/Shutterstock. Edgewise Therapeutics has ...
IVL uses sonic pressure waves to break up calcium deposits in coronary arteries. Image credit: Shutterstock / Marisa Maneesang. The market for intravascular lithotripsy (IVL), a procedure utilised to ...
Last year, the US Food and Drug Administration (FDA) placed a partial clinical hold on Phase III trials evaluating tolebrutinib in MS and myasthenia gravis, including the HERCULES study. Image credit: ...
The trial focuses on treating anaemia in patients with LR-MDS who have exhausted other treatment options. Credit: fizkes/Shutterstock. Ryvu Therapeutics has dosed the first subject in the Phase II ...
DermaSensor’s AI-based device helps clinicians detect common forms of skin cancer. Credit: mentalmind via Shutterstock. US-based DermaSensor has announced a newly published study showing that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback